Correlation Between Rigel Pharmaceuticals and Zenith Capital
Can any of the company-specific risk be diversified away by investing in both Rigel Pharmaceuticals and Zenith Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rigel Pharmaceuticals and Zenith Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rigel Pharmaceuticals and Zenith Capital Corp, you can compare the effects of market volatilities on Rigel Pharmaceuticals and Zenith Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rigel Pharmaceuticals with a short position of Zenith Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rigel Pharmaceuticals and Zenith Capital.
Diversification Opportunities for Rigel Pharmaceuticals and Zenith Capital
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Rigel and Zenith is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Rigel Pharmaceuticals and Zenith Capital Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zenith Capital Corp and Rigel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rigel Pharmaceuticals are associated (or correlated) with Zenith Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zenith Capital Corp has no effect on the direction of Rigel Pharmaceuticals i.e., Rigel Pharmaceuticals and Zenith Capital go up and down completely randomly.
Pair Corralation between Rigel Pharmaceuticals and Zenith Capital
Given the investment horizon of 90 days Rigel Pharmaceuticals is expected to generate 221.17 times less return on investment than Zenith Capital. But when comparing it to its historical volatility, Rigel Pharmaceuticals is 48.54 times less risky than Zenith Capital. It trades about 0.04 of its potential returns per unit of risk. Zenith Capital Corp is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest 0.01 in Zenith Capital Corp on December 1, 2024 and sell it today you would earn a total of 0.00 from holding Zenith Capital Corp or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Rigel Pharmaceuticals vs. Zenith Capital Corp
Performance |
| Timeline |
| Rigel Pharmaceuticals |
| Zenith Capital Corp |
Rigel Pharmaceuticals and Zenith Capital Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rigel Pharmaceuticals and Zenith Capital
The main advantage of trading using opposite Rigel Pharmaceuticals and Zenith Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rigel Pharmaceuticals position performs unexpectedly, Zenith Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zenith Capital will offset losses from the drop in Zenith Capital's long position.| Rigel Pharmaceuticals vs. Fortress Biotech | Rigel Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Rigel Pharmaceuticals vs. Cidara Therapeutics | Rigel Pharmaceuticals vs. X4 Pharmaceuticals |
| Zenith Capital vs. biOasis Technologies | Zenith Capital vs. Hemogenyx Pharmaceuticals Plc | Zenith Capital vs. ProMIS Neurosciences | Zenith Capital vs. Fennec Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |